Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…uorouracil, cisplatin+fluorouracil and oxaliplatin+leucovorin + fluorouracil regimens were administered to 46 (67%), 4 (6%) and 19 (27%) pat…
…ansen JS, Larsen FO, Theile S, Hasselby JP, Willemoe GL, et al. Nivolumab with or without ipilimumab combined with stereotactic body radi…
…sions These findings provide a rationale for the combination of STAR0602 and SOC therapy in the clinical setting for patients with recur…
…erse events were reported in 53.5% (23/43) patients.Conclusions Cadonilimab combined with taxane and cisplatin as first-line treatment reve…
…usion These findings provide a rationale for the combination of STAR0602 and SOC therapy in the clinical setting for patients with recur…
… compared two intravenous adjuvant regimens, demonstrating that gemcitabine plus cisplatin (GP) outperformed the traditional fluorouracil p…
…from 50% to 70%3 7 8 for intravenous AC and 70% to 80% for oral capecitabine.1 2 This cohort offers valuable insights into real-world experi…
…induction chemotherapy and CCRT, oral chemotherapy, either with capecitabine or S-1, was efficacious and tolerable.…
… symptom control and lower therapy inadequacy risks compared to metoclopramide.Conclusions Ondansetron is superior to metoclopramide for preve…
…poor. The PERICLES study explored a novel strategy of combining atezolizumab with radiation therapy for patients with advanced PeCa. 65 Howe…
…tinum salts (carboplatin, oxaliplatin, cisplatin), and taxanes (paclitaxel, docetaxel).Methods This single-centre, retrospective study was…
…isease. Patients receive six 3-week cycles of systemic therapy: pucotenlimab 200 mg IV on day 1; TMZ 200 mg/m² orally on days 1–5 and DDP 25…